NNMX — Nanomix Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $11.46m
- $0.02m
Annual balance sheet for Nanomix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.012 | 0.007 | 0.007 | 0.297 | 0.017 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | — | 0 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.922 | 0.023 | 0.02 | 0.469 | 0.08 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0.001 | 0 | 0.339 | 0.833 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1.44 | 0.024 | 0.02 | 0.906 | 0.982 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.66 | 7.7 | 8.6 | 3.33 | 4.05 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.59 | 7.7 | 8.6 | 6.94 | 14.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -4.15 | -7.67 | -8.58 | -6.04 | -13.2 |
| Total Liabilities & Shareholders' Equity | 1.44 | 0.024 | 0.02 | 0.906 | 0.982 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |